Table 2.
Comparison between IDUs infected with HIV subtype F vs. non-F
| F subtype n=25 |
non-F subtypes n=12 |
P | |
|---|---|---|---|
| Malesa | 22 (88) | 11 (91.6) | 0.9 |
| Median age, years (range) | 25 (15–45) | 27 (15–42) | 0.62 |
| Median age at initiation of drug use, years (range) | 16.5 (11–34) | 17 (14–30) | 0.56 |
| Median time on drugs, months (range) | 78 (6–180) | 82 (12–180) | 0.64 |
| Patients on heroin onlya | 5 (20) | 3 (25) | 0.7 |
| Patients on NPS onlyab | 4 (16) | 2 (16.6) | 0.9 |
| Patients on NPSb with/after heroina | 15 (60) | 8 (66.6) | 0.6 |
| Median CD4 count, cells/ml (range) | 697 (39–1988) | 226 (25–530) | 0.001* |
| Patients with CD4 < 200 cells/mla | 2 (8) | 5 (41.6) | 0.02* |
| Median HIV RNA, log10 copies/ml (range) | 4.8 (3.7–6.2) | 5.5 (3.9–6.7) | 0.07 |
Legend of table:
a
All values are patients numbers, (%), unless otherwise indicated.
b
NPS- new psychoactive substances.
*
p<0.05 was considered statistically significant.